Doctor profile · Federal record
Dr. Mark Kris, MD
Medical Oncology Physician (CMS: Medical Oncology) · New York, NY
- NPI 1174594113
- Accepts Medicare
- MIPS 84.6 / 100 · 2023
- 49 yrs in practice
- Male
- No sanctions
Practice & contact
- Primary practice
-
1275 York Ave
New York, NY 100216007
(646) 227-3813 - Mailing address
-
633 3Rd Ave, Box 3
New York, NY 100176706
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1977 — 49 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- New York #134739
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1174594113. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
710
Distinct HCPCS
4
Medicare allowed
$80,914
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 394 | 118 | $109 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 168 | 89 | $74 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 111 | 57 | $160 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 37 | 37 | $204 |
In context: peer comparison
Among 122 peers in this city , average services per provider: 215. This provider delivers 3.3× the peer median.Open Payments
Industry payments received
All-time total
$10,211
Transactions
13
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $5,462.58 | |
| Daiichi Sankyo Inc. | 1 | $1,640.00 | |
| AstraZeneca UK Limited | 1 | $1,541.25 | |
| Merck Sharp & Dohme LLC | 1 | $1,525.00 | |
| Genentech, Inc. | 1 | $41.84 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
542
Patients
139
Total drug cost
$3,605,268
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tagrisso (Osimertinib Mesylate) | Brand | 159 | 19 | $2,763,021 |
| Omeprazole | Generic | 72 | 21 | $768 |
| Dexamethasone | Generic | 59 | 37 | $889 |
| Prednisone | Generic | 35 | 17 | $245 |
| Alecensa (Alectinib Hcl) | Brand | 33 | 0 | $521,968 |
| Ondansetron Hcl | Generic | 30 | 21 | $366 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 27 | 13 | $173 |
| Lorbrena (Lorlatinib) | Brand | 23 | 0 | $306,144 |
| Olanzapine | Generic | 18 | 11 | $485 |
| Famotidine | Generic | 16 | 0 | $185 |
Frequently asked questions
What is Dr. Mark Kris's medical specialty?
Dr. Mark Kris practices Medical Oncology Physician in New York, NY.
Where does Dr. Mark Kris practice?
Dr. Mark Kris practices at 1275 York Ave, New York, NY 100216007. Office phone: 6462273813.
What is Dr. Mark Kris's NPI?
Dr. Mark Kris's National Provider Identifier (NPI) is 1174594113, issued by NPPES.
Does Dr. Mark Kris accept Medicare assignment?
Yes. Dr. Mark Kris accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Kris commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.